| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Director | Common Stock | 75K | $5.12M | $68.26 | May 9, 2025 | By Trust |
| Envista Holdings Corp | Director | Common Stock | 44.7K | $829K | $18.55 | Jun 10, 2025 | Direct |
| Edwards Lifesciences Corp | Director | Common Stock | 4.68K | $320K | $68.26 | May 9, 2025 | Direct |
| ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | Mar 11, 2022 | By The Gallahue Irrevocable Trust | |
| ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
| ARENA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct | ||
| Intersect ENT, Inc. | Director | Common Stock | 0 | $28.25 | May 13, 2022 | Direct | |
| Intersect ENT, Inc. | Director | Common Stock | 0 | $28.25 | May 13, 2022 | Indirect | |
| Intersect ENT, Inc. | Director | Stock Options (Right to buy) | 0 | $28.25 | May 13, 2022 | Direct |